nomela®
Melanoma risk-assessment technology
Non-invasive diagnostic aid to indicate the probability of melanoma in pigmented skin lesions (moles)
On-device AI by machine-learning
Single-application iPads
For use by medical professionals
Intended positioning for the management of patients referred on the urgent suspicion of skin cancer at triage in secondary care
Applies automated edge detection to exclude surrounding skin
Cyber Security Plus certified
QMS ISO 13485 certified
The nomela® test
nomela® features
Support
Fully integrated infrastructure with easy input to electronic patient records (EPR). Connectivity, device delivery, updates, replacements
and 24-hour help-line.
Process flows
Easy integration of nomela® reports into electronic patient records. Standalone infrastructure for surveillance of diagnosis and location and regional overview of activity via real-time dashboard.